Rezolute Inc. (RZLT)
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
Press Release: Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
Lithium Ionic to Present at the Fastmarkets Global Lithium, Battery & Critical Materials Conference in Las Vegas
OTC Markets Group Welcomes Starcore International Mines Ltd. to OTCQX
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2026
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
Carrier Announces Leadership Transition for Its Climate Solutions Europe Segment; Thomas Donato Appointed President
TDG Announces Positive Results from Ongoing Metallurgical Test Work - Conventional Processing Achieves >90% Gold and Silver Recoveries At Shasta, Toodoggone District
Brazil Potash contrata WSP UK e Redpath Deilmann para o feed dos poços e do desenvolvimento subterrâneo da mina, completando a cobertura de engenharia de todo o Projeto Autazes
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026